Herpes simplex virus thymidine kinase (HSV-TK) and
Introduction
Adenoid cystic carcinomas (ACCs) are malignant tumours that originate in the major and minor salivary glands. 1 This type of tumour was first reported by Billroth 2 in 1859 who described it as a benign tumour and called it a cylindroma. Subsequently the tumours were shown to recur insidiously, often over many years, with eventual death of the patient. 3 These tumours consist of epithelial and myoepithelial cells and are slow-growing malignant tumours characterized by wide local infiltration, perineural spread and a propensity for local recurrence. 1 A combination of radical surgery, radiotherapy and chemotherapy
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significantly decreases the rate of local recurrence when compared with surgery alone, 1, 4 however, in unresectable cases, or where there is local recurrence after surgery, no efficient treatment strategy has been developed. The disease-free survival rates are 66% for 3 years, 57% for 5 years and 41% for 10 years. 5 Interest has, therefore, been in the development of new treatment modalities because of the significant limitations of currently used local and systemic therapies for ACCs. 6 Reported response rates to combination chemotherapy for ACCs are low and the response is generally short-lived. 6 One of the major obstacles encountered with chemical modifiers of cancer treatment is the difficulty in identifying biochemical characteristics unique to malignant cells that could be exploited therapeutically. Recent advances in the molecular biology of gene transduction have permitted significant progress in the treatment of cancer using gene therapy. An appealing approach has been to incorporate a drug susceptibility gene, or 'suicide gene' within the tumour, which encodes an enzyme that allows the transduced tumour cells to activate a normally innocuous compound (pro-drug) to a cytotoxic form that kills the tumour cells. The most studied of these strategies involves transfer of the bacterial cytosine deaminase (CD) gene or the herpes simplex virus thymidine kinase (HSV-TK) gene into tumour cells, which are selectively sensitized to 5-fluorocytosine (5-FC) or ganciclovir, respectively. 7 -9 Tumour cells that express CD can selectively convert its substrate, 5-FC, into the toxic anabolite 5-fluorouracil (5-FU), which is further processed by cellular enzymes into either 5-fluorouracil triphosphate (5-FUTP) or 5-fluoro-2′-deoxyuridine 5′-monophosphate (5-FdUMP). The 5-FUTP is incorporated into RNA and interferes with RNA processing, whereas 5-FdUMP irreversibly inhibits thymidylate synthase and hence DNA synthesis. 7, 8 Tumour cells expressing viral HSV-TK are able initially to phosphorylate ganciclovir, leading to accumulation of its cytotoxic metabolite, ganciclovir triphosphate, and subsequent incorporation into DNA and apoptosis. 9 -11 In addition to direct cytotoxicity to the transduced cells, it has been demonstrated that significant toxicity from these two converted pro-drugs can be transmitted to adjacent cells, a process known as the 'bystander' effect -the ability of suicide enzyme-expressing cells to sensitize neighbouring non-expressing bystander cells to the pro-drug. 12 Potent cytotoxicity and bystander killing have resulted in excellent activity in many different types of tumour cells in vitro and produced marked tumour regression in several animal models. 12 -15 The effectiveness of ganciclovir in the killing of ACCs transduced with a vector containing HSV-TK has been demonstrated in vitro. 16, 17 Sun et al. 16 studied the effects of HSV-TK gene transduction on ACC cells and showed that such transduction did not greatly change the biological character of ACC tumour cells. Zhang et al. 17 recently indicated that apoptosis induced by the HSV-TK/ganciclovir system in human ACC-M cells occurs via a caspase-3 pathway and that the activation of caspase-3 was not involved in the bystander effect of the HSV-TK/ganciclovir system. Sun et al. 18 demonstrated in vivo that HSV-TK-positive tumours could be eliminated by systemic treatment with ganciclovir without significant toxicity to the host, however this approach was not effective when the solid tumours were grossly large. There has been no study of the effect of CD gene therapy on ACCs of the salivary glands. Radiotherapy for cancer gains its  therapeutic advantage by exploiting  differences between malignant and normal  tissue with respect to repair, cell-cycle  distribution, re-population and reoxygenation, and by restricting the radiation dose to normal tissues. 19 ACC is relatively radiosensitive and may have a doseresponse relationship with radiation, 20, 21 but positive surgical margins may represent resistant disease. 22 Indeed, Kreitner et al. 23 reported that radiotherapy with a total dose of 70 -80 Gy achieved good local control in all patients with ACC. It is, however, generally considered difficult to deliver ≥ 70 Gy with conventional radiotherapy, hence new radiobiological studies are needed to explore the effects of fusion gene therapy on ACCs. The rationale of the present radiobiological study is based on the fact that the non-toxic pro-drug, 5-FC, and ganciclovir are activated within tumours expressing CD and HSV-TK. As stated above, the cytotoxic effect of the CD/5-FC combination is mediated predominantly through inhibition of thymidylate synthase by 5-FdUMP. 7, 8 This results in a redistribution of cells in early S phase, 24 as well as DNA strand breakage due to the disruption of deoxynucleotide pools. 25 The cytotoxicity of the HSV-TK/ganciclovir system results from inhibition of DNA polymerases by ganciclovir monophosphate, which leads to disruption of DNA synthesis. 9 -11 It was suggested, therefore, that the CD/5-FC and HSV-TK/ganciclovir systems may act synergistically when combined, because CD/HSV-TK-expressing cells would accumulate in the early S phase, the point at which they are most sensitive to ganciclovir. Ganciclovir might also inhibit the repair of DNA strand breaks caused by 5-FC treatment. Several authors have integrated the CD/5-FC and HSV-TK/ganciclovir strategies which, when combined together, have been found to be more effective compared with the use of either strategy alone. 14, 26 Moreover, 5-FU (the product of the CD reaction) and its intermediary metabolites are proven radiosensitizers. 24, 25 As yet, few radiobiological studies have been carried out to explore the effects of fusion gene therapy on ACCs of the salivary glands. On the basis of the studies discussed above, it was hypothesized that the addition of radiation would improve the therapeutic potential of CD and HSV-TK fusion gene therapy for the treatment of human ACCs.
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Radiosensitization and anti-tumour effects in ACC cells
The present study was designed to demonstrate in vitro that the use of liposomes provides an efficient approach for ACC-2 targeted gene transfer. This study also investigated whether, by using liposomes, it was possible to show co-expression of the CD-TK fusion gene in ACC-2 cell lines, to select gene-transduced tumour cells in G418 medium, and whether radiosensitizing effects could be observed in ACC-2 cell lines that had been transduced with the CD and HSV-TK fusion genes and exposed to ganciclovir and 5-FC prior to irradiation.
Materials and methods
CELL LINES AND CELL CULTURE
Studies were carried out with ACC-2 cells (kindly provided by the Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China), which were cultured in RPMI 1640 medium (Gibco Biocult, Paisley, UK) containing 10% heatinactivated fetal bovine serum (Gibco ® -BRL Life Technologies™, Grand Island, NY, USA) and 2 mmol/l glutamine. The ACC-2 cells were maintained in exponential growth in a humidified incubator at 37°C in an atmosphere of 5% CO 2 .
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GENE TRANSFER
Cell transfection was carried out by means of liposomes, using Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA, USA) as the transfection solution, according to the manufacturer's instructions. Briefly, ACC-2 cells were grown to 80 -90% confluence without antibiotics. Eukaryotic expression pIRES vectors (Sijia Biochemical, Shanghai, China) that contained the CD-TK fusion gene (20 µg) were diluted in RPMI 1640 (100 µl) and mixed with the transfection solution for 15 min. After washing, the ACC-2 cells were incubated with the transfection solution at 37°C for 6 h and then allowed to grow in fresh RPMI 1640 medium. To obtain an enriched population of transduced cells, the ACC-2/CD-TK tumour cells were selected with 400 µg/ml G418 medium (Gibco ® -BRL Life Technologies™) for 2 weeks. Pools of G418-resistant clones were passaged and expanded for reverse transcriptionpolymerase chain reaction (RT-PCR) and Western blotting analysis.
RT-PCR ANALYSIS
Cells were harvested in TRIzol ® (Gibco ® , Carlsbad, CA, USA) and passed through a 28-gauge needle-fitted syringe to shear DNA. The RNA was extracted and purified by phenol-chloroform, precipitated with isopropanol, dissolved in RNase-free water and stored at −20°C until used. For the analysis of CD-TK expression, first-strand cDNAs were synthesized from 2 µg total RNA in 20 µl of a reaction mix containing 2.5 µmol/l of random hexadeoxynucleotide primers, 10 mmol/l Tris-HCl (pH 8.3), 50 mmol/l KCl, 5 mmol/l MgCl 2 , 0.5 mmol/l of each deoxynucleotide triphosphate (dNTP) and 50 U murine leukaemia virus RT (Perkin Elmer, Foster City, CA, USA). After incubation for 1 h at 42°C, the reaction was stopped by heating at 99°C for 5 min.
Aliquots of the cDNAs were amplified by PCR in a reaction mixture consisting of 1 µl RT cDNA product, 10× PCR buffer, 1.5 mmol/l MgCl 2 , 0.2 mmol/l of each dNTP, 0.2 µmol/l of each cystathionine β-synthase primer and 1.25 U Taq DNA polymerase (Tiangen Biochemical, Beijing, China). The PCR was performed for 28 cycles of 1 min at 94°C (denaturation), 1 min at 70°C (annealing) and 1 min at 72°C (extension) in a Superscript™ First Strand Synthesis System (Life Technologies, Gaithersburg, MD, USA) using the CD-TK-specific primer (sense, 5′-TGTCGAATAAACGCTTTACAAAC-3′; antisense, 5′-AACGTTTGTAATGATGGCTTCTG-3′). After PCR amplification, the product was separated on a 2% (w/v) agarose gel in TAE buffer (Tris, 40 mmol/l; disodium EDTA [ethylenediamine tetraacetate], 1 mmol/l; sodium acetate, 40 mmol/l [pH 8.0]), stained with 0.5 µg/ml ethidium bromide, and photographed under ultraviolet light. β-Actin transcripts were used to control for the RNA that was used to amplify the genes by RT-PCR.
WESTERN BLOTTING ANALYSIS
The ACC-2 cells from transfected and nontransfected cell lines (at least 10 6 cells in total) were washed once with cold 10 mM phosphate-buffered saline (PBS), pH 7. 
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separated on 10% reducing sodium dodecyl sulphate-polyacrylamide gel and transferred to a nitrocellulose membrane (Schleicher and Schuell, Keene, NH, USA). The membranes were blocked with 5% non-fat milk in PBS containing 0.05% Tween ® 20 (PBST) for 1 h at room temperature and incubated with primary antibodies overnight at 4°C. Human CD or TK monoclonal antibodies (Sigma-Aldrich, St Louis, MO, USA) were applied at 1:1000 dilution. Membranes were washed three times for 10 min in PBST before incubation for 1 h at room temperature with horseradish peroxidase (HRP) and conjugated secondary antibodies (bovine anti-sheep HRP, 1:3000; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After six 5-min washes in PBST and one 20-min wash in PBS, the membranes were incubated with enhanced chemiluminescence substrate (Pierce Biotechnology) for 1 min before exposure to Kodak™ X-Omat AR film (Eastman Kodak, Rochester, NY, USA). Membranes were re-probed with β-actin as a loading control.
CYTOTOXICITY AND RADIOSENSITIVITY ASSAYS
Surviving colonies were pooled for subsequent radiation and cytotoxicity studies of 5-FC and ganciclovir. The drugs ganciclovir and 5-FC were purchased from Sigma-Aldrich. For cytotoxicity studies, ACC-2 and ACC2/CD-TK cells were incubated for 48 h with 20 µg/ml 5-FC plus 0.01 µg/ml ganciclovir, 40 µg/ml 5-FC plus 0.1 µg/ml ganciclovir, 80 µg/ml 5-FC plus 1 µg/ml ganciclovir, or 160 µg/ml 5-FC plus 10 µg/ml ganciclovir.
For radiation studies, ACC-2 and ACC2/CD-TK cells were irradiated at room temperature, either before or after treatment with 40 µg/ml 5-FC plus 0.1 µg/ml ganciclovir using a Theratron ® 80 cobalt-60 unit (Theratronics International, Carrollton, TX, USA) to deliver a single dose of X-ray irradiation of 0 -8 Gy at a rate of 1 -2 Gy/min. Dosimetry was carried out using a Baldwin ionization chamber connected to an electrometer system that was directly traceable to a National Bureau of Standards calibration. 27 Full electron equilibrium was ensured for all irradiations. After drug exposure and/or irradiation, cells were plated in drug-free RPMI 1640 medium.
Clonogenic survival was determined by counting crystal violet-stained colonies (cell aggregates of > 50 cells) 14 days after treatment. Cytotoxicity was assessed using cell survival curves in which the percentage of cells that survived a radiation dose with and without the drug was plotted as a function of radiation dose. Each experiment was repeated at least twice. Cells were actively dividing and asynchronous at the time of drug and irradiation treatment.
Cell survival data and the colony formation rate after irradiation at 2 Gy (SF 2 ) were analysed using a single-hit multi-target model. 28 The sensitization enhancement ratio (SER) was calculated by dividing the SF 2 value in ACC-2 cells with the SF 2 value in ACC-2/CD-TK cells. Radiosensitivity was defined by the slope (D 0 ) of the linear portion of the survival curve as plotted on a semilogarithmic scale. The shoulder of the survival curve (D q ) was taken to reflect the ability of the cell population to accumulate sub-lethal damage and, subsequently, to repair the damage.
STATISTICAL ANALYSIS
Survival curves were fitted using SPSS ® version 10.0 software (SPSS Inc., Chicago, IL, USA). Statistical analysis and data fitting for radiosensitivity assays were performed using SigmaPlot ® Demo version 10.0 (SPSS Inc.). Differences in radiosensitivity between cell
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lines were analysed statistically with a Student's t-test. Statistical significance was defined at the level of P < 0.05.
Results
RT-PCR ANALYSIS
After gene transfection, ACC-2 cell clones transfected with the pIRES-CD-TK vector were obtained. To address whether the transfected pIRES-CD-TK vector could lead to co-expression in ACC-2 cells, total RNA was assayed by quantitative RT-PCR (Fig. 1) . PCR analysis demonstrated that the CD-TK fusion gene existed in transfected ACC-2 cells.
WESTERN BLOTTING ANALYSIS
Immunoblotting using human CD or TK monoclonal antibody to determine CD-TK protein expression resulted in specific bands corresponding to the expected molecular weights of 48 kDa (CD) and 41 kDa (TK) (Fig.   2 ). The same filters used for thymidylate synthase detection were subsequently developed using a β-actin antibody in order to obtain a quantitative internal control (Fig. 2) .
SENSITIVITY OF ACC-2 AND ACC-2/ CD-TK CELLS TO GANCICLOVIR PLUS 5-FC
The cytotoxic effects of 5-FC and ganciclovir without irradiation were determined as a function of time. As shown in Fig. 3A , at all doses and treatment periods of ganciclovir and 5-FC, the survival of parental ACC-2 cells was > 50%. In contrast, when ACC-2/ CD-TK cells were exposed to ganciclovir and 5-FC, significant toxicity was seen compared with the ACC-2 parental cells (P < 0.05). For example, at a concentration of 80 µg/ml 5-FC plus 1 µg/ml ganciclovir and a 72 h exposure time, the survival of ACC-2/CD-TK cells was significantly reduced to 55.58% (P < 0.05; Fig. 3B ), whereas the survival of parental ACC-2 cells showed relatively little change (Fig 3A) . The cell growth rate and 
RADIOSENSITIVITY OF ACC-2/CD-TK CELLS TREATED WITH GANCICLOVIR AND 5-FC
The survival of ACC-2 and ACC-2/CD-TK cells after exposure to 5-FC (40 µg/ml) plus ganciclovir (0.1 µg/ml) for 48 h before or after various doses of irradiation is shown in Fig. 4 . Toxicity from the drugs alone at this drug dose in the absence of irradiation was minimal to moderate during the 72 h treatment period (Fig. 3A, 3B ). The radiosensitivity of parental ACC-2 cells was not altered by the drugs (Fig. 4A, 4B ). As expected, however, a significant (P < 0.01) radiosensitizing effect of 5-FC plus ganciclovir was observed in ACC-2/CD-TK cells exposed to the drugs before irradiation (Fig. 4C) ; irradiation exposure prior to exposure to the drugs had no significant effect on survival (Fig. 4D) . The survival curve parameters, derived using a single-hit, multi-target model, are listed in Table 1 . Radiation survival curves for cells exposed to 5-FC plus ganciclovir before irradiation were characterized by higher D q and D 0 values for parental ACC-2 cells than for ACC-2/CD-TK cells. Thus, irratiation resulted in increased radiationinduced cytotoxicity (SER = 2.313). A different pattern was found when cells were treated with 5-FC plus ganciclovir after irradiation: the D 0 value of the ACC-2 cells was similar to that of the ACC-2/CD-TK cells and the D q value was larger for the ACC-2 cells than for the ACC-2/CD-TK cells. The SF 2 value was larger for parental ACC-2 cells than for ACC-2/CD-TK cells.
Discussion
The present study demonstrates that the use of liposomes in vitro provides an efficient approach for ACC-2 targeted gene transfer. After using liposomes for gene transfer, co-Radiosensitization and anti-tumour effects in ACC cells expression of the CD-TK fusion gene was detected in ACC-2 cell lines and selected gene-transduced tumour cells in G418 medium (Figs 1 and 2) . Neither ganciclovir nor 5-FC had any marked effect on parental ACC-2 cells. In contrast, when ACC-2/CD-TK cells were exposed to ganciclovir plus 5-FC, toxicity was seen (Fig. 3) . It has been suggested that an advantage of combining pro-drugs is the possibility of reducing the doses used. 13, 15 The activation of pro-drugs to produce cytotoxicity in tumour cells is now considered a potential therapeutic strategy for cancer treatment. 14, 29, 30 For example, Xu et al. 14 demonstrated that gene therapy with the recombinant adenovirus-mediated CDglyTK double suicide gene is effective in destroying keloid fibroblasts and provides a sound scientific rationale for trials with keloids in vivo. Faneca et al. 30 indicated that suicide gene therapy has the potential to overcome some of the major limitations of conventional chemotherapy and may hold promise for future applications in antitumour therapy.
The present study also demonstrated clearly that a combination of 5-FC and ganciclovir increased the radiation-induced lethality of human ACC cells expressing the CD-TK fusion gene. The degree of increase in cell kill obtained with 5-FC plus ganciclovir was clearly dependent on drug concentration and the timing of exposure to the drugs with respect to irradiation (Figs 3  and 4 ). This potentiating effect was evident only in cells that had been exposed to drug treatment prior to irradiation. Exposure of cells to the drug after irradiation did not enhance the radiation response, suggesting that 5-FC plus ganciclovir does not interfere with the post-irradiation repair process. Despite the clinically favourable results of combined modality treatment regimens with 5-FC plus ganciclovir and radiation therapy for the treatment of a variety of common human malignancies, laboratory studies on the interaction between radiation and 5-FC plus ganciclovir are limited and contradictory. Smalley et al. 31 reported radiosensitization in the cell lines HT-29 and DU-145 when 5-FC was present continuously after irradiation. Lee et al. 32 reported that the CD-TK gene product activated the prodrugs 5-FC and ganciclovir and subsequently Their results are consistent with the data from the present study. Data from von der Maase, 33 however, showed no effect of 5-FU on radiation sensitivity in C3H/Tif mammary carcinoma and leukaemia cells. These differences suggest that radiosensitization by 5-FC and ganciclovir may depend on the cell line, which may explain, in part, some of the contradictory results regarding 5-FC and ganciclovir radiation interaction.
In the present study, considerable differences in radiobiological characteristics were observed between ACC-2 and ACC-2/CD-TK cells with respect to the D 0 and SER values of the radiation survival curves (Fig. 4 and Table 1 ). The D 0 value obtained when the cells were exposed to 5-FC plus ganciclovir before irradiation was greater for ACC-2 than for ACC-2/CD-TK cells and increased radiation-induced cytotoxicity was found (SER = 2.313). However, when cells were treated with the drugs after irradiation, the D 0 value for ACC-2 cells was similar to that of ACC-2/CD-TK cells and radiationinduced cytotoxicity was not increased. For drug treatment prior to irradiation, the SF 2 value was greater for parental ACC-2 cells than for ACC-2/CD-TK cells, suggesting that radiosensitization occurred in the ACC-2/CD-TK cells. Some investigators, however, who have studied suicide gene/pro-drug therapy systems have not described this phenomenon. For example, Kim et al. 34 transduced gliosarcoma cells with a retrovirus encoding HSV-TK, added ganciclovir and exposed the cells to radiation and showed no change in radiosensitivity compared with the control group. On the other hand, Wu et al. 35 investigated the killing effect and radiosensitization of double suicide genes mediated by adenovirus on colorectal carcinoma cells and their results are consistent with the data in the present study in demonstrating that CD-TK fusion gene systems can increase radiosensitization of colorectal carcinomas.
In vitro, radiosensitivity is traditionally defined by the slope (D 0 ) of the linear portion of the survival curve as plotted on a semilogarithmic scale. However, the shoulder of the survival curve (D q ) may be the more important parameter from which to extrapolate information for clinical fractionated radiation therapy. The value of D q is postulated to reflect the ability of a cell population to accumulate sub-lethal damage and, subsequently, to repair the damage. 24, 25 Of interest is the difference in the D q values for the ACC-2 and ACC-2/CD-TK cells exposed to 5-FC plus ganciclovir before irradiation. The D q of 1.736 Gy observed in the present study for parental ACC-2 cells implied that they had a relatively high degree of radioresistance, correlating with a relatively large capacity for repair of sub-lethal damage. However the D q of ACC-2/CD-TK cells exposed to 5-FC plus ganciclovir before irradiation was low (0.112), indicating a greater capacity to accumulate sub-lethal damage at lower radiation doses. The mechanism of sub-lethal damage repair is poorly understood, however these observations may be of importance in exploring the underlying molecular mechanism of radiation damage and repair in human adenoid cystic carcinoma.
The mechanisms underlying radiosensitization are poorly understood, however studies have suggested that cells treated with 5-FU accumulate in the early S phase, a radiosensitive phase of the cell cycle. 25, 36 Unlike mammalian thymidine kinase, HSV-TK can phosphorylate ganciclovir and the monophosphate form of ganciclovir is subsequently phosphorylated by endogenous cellular kinases to the triphosphate form, which inhibits DNA polymerase and, The radiosensitization effect of the CD/5-FC combination may be due to the accumulation of cells in early S phase and a consequent increase in DNA strand breakage. 25, 36 In contrast, the radiosensitization effect of the HSV-TK/ganciclovir combination is probably due to inhibition of the repair of potentially lethal damage. 26 Thus, following double prodrug treatment, CD-TK-expressing cells suffer increased DNA strand breakage after ionizing radiation (due to the CD/5-FC system) and concomitantly are unable to replicate and repair DNA (due to the HSV-TK/ganciclovir system).
In conclusion, the results of the present study show an improved therapeutic effect of combined treatment with 5-FC and ganciclovir administered before radiation when tumour cells are transduced with the CD and HSV-TK fusion genes. This suggests that the combination of radiotherapy and the CD/5-FC plus HSV-TK/ganciclovir strategy has considerable potential to increase the efficacy of radiation in patients with ACC.
